Brett Hale Sells 24,188 Shares of Hyperfine (NASDAQ:HYPR) Stock

Key Points

• Hyperfine CFO Brett Hale sold 24,188 shares on March 23 at an average price of $1.21, trimming his stake by 8.06% to 275,812 shares valued around $333,732.
• HYPR trades near $1.17 with a market cap of about $113.7M and a 12‑month range of $0.53–$2.22; the company remains unprofitable with negative margins and P/E, though it beat last quarter's EPS estimate (-$0.06 vs. -$0.08) on roughly $5.29M revenue.
• Analysts hold a consensus Hold rating (average target $1.45) amid mixed views—Lake Street raised its target to $2.50—and institutional investors have recently increased positions, with ~15.03% owned by hedge funds and other institutions.

Hyperfine, Inc. (NASDAQ:HYPR - Get Free Report) CFO Brett Hale sold 24,188 shares of the stock in a transaction on Monday, March 23rd. The shares were sold at an average price of $1.21, for a total value of $29,267.48. Following the completion of the transaction, the chief financial officer directly owned 275,812 shares in the company, valued at approximately $333,732.52. This represents a 8.06% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Hyperfine Price Performance

HYPR stock traded up $0.02 during mid-day trading on Wednesday, hitting $1.17. 352,549 shares of the stock were exchanged, compared to its average volume of 502,890. The business has a fifty day moving average price of $1.16 and a 200 day moving average price of $1.20. Hyperfine, Inc. has a 12 month low of $0.53 and a 12 month high of $2.22. The stock has a market capitalization of $113.69 million, a price-to-earnings ratio of -2.66 and a beta of 1.09.

Hyperfine (NASDAQ:HYPR - Get Free Report) last announced its quarterly earnings data on Wednesday, March 18th. The company reported ($0.06) EPS for the quarter, beating the consensus estimate of ($0.08) by $0.02. The firm had revenue of $5.29 million for the quarter, compared to analyst estimates of $5.30 million. Hyperfine had a negative return on equity of 95.09% and a negative net margin of 262.29%. As a group, equities analysts forecast that Hyperfine, Inc. will post -0.57 EPS for the current fiscal year.

Analyst Ratings Changes

HYPR has been the topic of several research reports. Lake Street Capital lifted their price target on shares of Hyperfine from $2.00 to $2.50 and gave the stock a "buy" rating in a research note on Thursday, March 19th. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Hyperfine in a research note on Thursday, January 22nd. Finally, Zacks Research raised shares of Hyperfine to a "hold" rating in a report on Thursday, March 19th. Two research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Hyperfine has a consensus rating of "Hold" and an average target price of $1.45.

Institutional Investors Weigh In On Hyperfine

Several institutional investors have recently bought and sold shares of HYPR. EP Wealth Advisors LLC purchased a new position in Hyperfine in the 4th quarter worth approximately $34,000. XTX Topco Ltd grew its holdings in shares of Hyperfine by 47.9% in the fourth quarter. XTX Topco Ltd now owns 80,735 shares of the company's stock worth $79,000 after purchasing an additional 26,165 shares during the last quarter. Millennium Management LLC purchased a new position in shares of Hyperfine in the fourth quarter worth $55,000. Catalio Capital Management LP raised its holdings in Hyperfine by 92.8% during the 4th quarter. Catalio Capital Management LP now owns 1,320,041 shares of the company's stock valued at $1,293,000 after buying an additional 635,500 shares during the last quarter. Finally, Bridgeway Capital Management LLC boosted its position in Hyperfine by 50.2% during the 4th quarter. Bridgeway Capital Management LLC now owns 119,700 shares of the company's stock valued at $117,000 after buying an additional 40,000 shares during the period. 15.03% of the stock is currently owned by hedge funds and other institutional investors.

About Hyperfine

Hyperfine, Inc NASDAQ: HYPR is a medical technology company focused on expanding access to advanced neuroimaging through its portable magnetic resonance imaging (MRI) system. The company's flagship product, Swoop®, is designed to enable bedside MRI scanning in a wide range of clinical environments, including emergency departments, intensive care units and outpatient clinics. By leveraging a compact, high-performance permanent magnet and a custom-designed gradient system, Hyperfine aims to reduce the logistical and financial barriers associated with traditional, large-scale MRI installations.

The Swoop system features a lightweight, wheeled design that can be maneuvered directly to a patient's bedside, allowing clinicians to conduct diagnostic imaging without the need to transport critically ill or immobile patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.